Methylene Blue Reduces Mortality in Critically Ill and Perioperative Patients: A Meta-Analysis of Randomized Trials

医学 围手术期 病危 荟萃分析 随机对照试验 重症监护医学 内科学 麻醉 外科
作者
Alessandro Pruna,A. Bonaccorso,Alessandro Belletti,Stefano Turi,Ambra Licia Di Prima,Filippo D'Amico,Alberto Zangrillo,Yuki Kotani,Giovanni Landoni
出处
期刊:Journal of Cardiothoracic and Vascular Anesthesia [Elsevier BV]
卷期号:38 (1): 268-274 被引量:22
标识
DOI:10.1053/j.jvca.2023.09.037
摘要

Vasodilatory hypotension is common in critically ill and perioperative patients, and is associated with adverse outcomes. As a nitric oxide production inhibitor, methylene blue (MB) exerts its vasoconstrictor property and is an adjuvant for catecholamine-refractory vasodilatory shock. However, the effects of MB on clinically relevant outcomes remain unclear. Therefore, the authors performed a meta-analysis of randomized trials on MB in critically ill and perioperative patients. The authors searched through databases for randomized trials on MB in critically ill and perioperative patients, which yielded 11 studies consisting of 556 patients. The primary outcome was mortality at the longest follow-up. Secondary outcomes included hemodynamic parameters and organ dysfunction (PROSPERO: CRD42023409243). Nine out of the 11 included randomized trials reported mortality, which was significantly lower in the MB group (risk ratio, 0.60 [95% CI 0.43-0.84] p = 0.003), with findings confirmed in septic shock and cardiac surgery subgroups. The authors found reduced lengths of stay in the intensive care unit (mean difference [MD], −0.9 days [95% CI −1.06 to −0.77] p < 0.001) and in the hospital (MD, −2.2 days [95% CI, −2.68 to −1.70] p < 0.001) in the MB group. MB was associated with increased mean arterial pressure (MD, 8.4 mmHg [95% CI 5.01-11.75] p < 0.001) and systemic vascular resistance (MD, 94.5 dyn/s/cm5 [95% CI 17.73-171.15] p = 0.02), with no difference in cardiac output (standardized MD, 0.16 [95% CI, -0.25 to 0.57] p = 0.45). This meta-analysis showed that MB reverses vasodilation in critically ill and perioperative patients and might improve survival. Further adequately powered randomized trials are needed to confirm these findings. Vasodilatory hypotension is common in critically ill and perioperative patients, and is associated with adverse outcomes. As a nitric oxide production inhibitor, methylene blue (MB) exerts its vasoconstrictor property and is an adjuvant for catecholamine-refractory vasodilatory shock. However, the effects of MB on clinically relevant outcomes remain unclear. Therefore, the authors performed a meta-analysis of randomized trials on MB in critically ill and perioperative patients. The authors searched through databases for randomized trials on MB in critically ill and perioperative patients, which yielded 11 studies consisting of 556 patients. The primary outcome was mortality at the longest follow-up. Secondary outcomes included hemodynamic parameters and organ dysfunction (PROSPERO: CRD42023409243). Nine out of the 11 included randomized trials reported mortality, which was significantly lower in the MB group (risk ratio, 0.60 [95% CI 0.43-0.84] p = 0.003), with findings confirmed in septic shock and cardiac surgery subgroups. The authors found reduced lengths of stay in the intensive care unit (mean difference [MD], −0.9 days [95% CI −1.06 to −0.77] p < 0.001) and in the hospital (MD, −2.2 days [95% CI, −2.68 to −1.70] p < 0.001) in the MB group. MB was associated with increased mean arterial pressure (MD, 8.4 mmHg [95% CI 5.01-11.75] p < 0.001) and systemic vascular resistance (MD, 94.5 dyn/s/cm5 [95% CI 17.73-171.15] p = 0.02), with no difference in cardiac output (standardized MD, 0.16 [95% CI, -0.25 to 0.57] p = 0.45). This meta-analysis showed that MB reverses vasodilation in critically ill and perioperative patients and might improve survival. Further adequately powered randomized trials are needed to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Sigramm完成签到,获得积分10
刚刚
bofu发布了新的文献求助30
1秒前
该换手机发布了新的文献求助10
2秒前
2秒前
WeiBao发布了新的文献求助10
3秒前
rush完成签到,获得积分10
3秒前
3秒前
领导范儿应助含蓄康采纳,获得10
5秒前
Yulin Yu完成签到,获得积分10
6秒前
传奇3应助zh采纳,获得10
6秒前
bofu发布了新的文献求助10
8秒前
8秒前
ED应助阳阳采纳,获得10
8秒前
ran完成签到,获得积分10
8秒前
长情琦完成签到,获得积分10
8秒前
ssw发布了新的文献求助10
8秒前
等等等等完成签到,获得积分10
9秒前
11秒前
13秒前
wen完成签到,获得积分10
14秒前
15秒前
Lucas应助wbl1025采纳,获得30
15秒前
bofu发布了新的文献求助10
15秒前
落寞鞋子完成签到,获得积分10
15秒前
15秒前
zhaoqing完成签到,获得积分10
16秒前
啊啊发布了新的文献求助10
16秒前
16秒前
生椰拿铁不加生椰完成签到 ,获得积分10
17秒前
17秒前
华仔应助踏实的师采纳,获得10
17秒前
18秒前
小小雪完成签到 ,获得积分10
18秒前
上官若男应助天生下饭采纳,获得10
19秒前
zh发布了新的文献求助10
20秒前
愉快的代玉完成签到,获得积分10
20秒前
宵宫完成签到,获得积分10
21秒前
啊啊发布了新的文献求助10
21秒前
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975722
求助须知:如何正确求助?哪些是违规求助? 3520056
关于积分的说明 11200719
捐赠科研通 3256455
什么是DOI,文献DOI怎么找? 1798271
邀请新用户注册赠送积分活动 877490
科研通“疑难数据库(出版商)”最低求助积分说明 806390